36 life science listings in Sweden in 2017: ”They have the next Novo Nordisk”

In 2017, 36 pharmaceutical, biotech, and medtech companies went public on the Swedish stock market. Only two firms were listed in Denmark. Industry professionals predict that consequently, Sweden will house the future pharma giants while Denmark misses out on growth and jobs.

Photo: Nasdaq

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles